{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:02:31Z","timestamp":1790931751853,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.tips.2011.07.004","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T05:32:34Z","timestamp":1321421554000},"page":"694-699","source":"Crossref","is-referenced-by-count":23,"title":["Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now?"],"prefix":"10.1016","volume":"32","author":[{"given":"Philip","family":"Barter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry-Anne","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2011.07.004_bib0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2011.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2011.07.004_bib0015","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2080001","article-title":"Transfers and exchanges of esterified cholesterol between plasma lipoproteins","volume":"208","author":"Barter","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2011.07.004_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0305-0491(82)90252-8","article-title":"Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species","volume":"71","author":"Ha","year":"1982","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.tips.2011.07.004_bib0035","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1016\/S0021-9258(18)99088-5","article-title":"Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice","volume":"266","author":"Agellon","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2011.07.004_bib0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/364073a0","article-title":"Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein","volume":"364","author":"Marotti","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.tips.2011.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/01.ATV.19.4.1105","article-title":"Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression","volume":"19","author":"Plump","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2011.07.004_bib0050","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1074\/jbc.273.9.5033","article-title":"Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits","volume":"273","author":"Sugano","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2011.07.004_bib0055","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.ATV.20.9.2106","article-title":"Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis","volume":"20","author":"Rittershaus","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2011.07.004_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35018119","article-title":"A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits","volume":"406","author":"Okamoto","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.tips.2011.07.004_bib0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1194\/jlr.M600332-JLR200","article-title":"Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits","volume":"48","author":"Morehouse","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2011.07.004_bib0070","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI118751","article-title":"Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels","volume":"97","author":"Zhong","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2011.07.004_bib0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1194\/jlr.M300520-JLR200","article-title":"A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly","volume":"45","author":"Curb","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2011.07.004_bib0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1006\/pmed.1998.0340","article-title":"A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency","volume":"27","author":"Moriyama","year":"1998","journal-title":"Prev. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0085","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1001\/jama.299.23.2777","article-title":"Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk","volume":"299","author":"Thompson","year":"2008","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2011.07.004_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCGENETICS.108.817304","article-title":"Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study","volume":"2","author":"Ridker","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.tips.2011.07.004_bib0095","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.ATV.0000118278.21719.17","article-title":"Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib","volume":"24","author":"Clark","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2011.07.004_bib0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0105","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(07)61088-5","article-title":"Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial","volume":"370","author":"Bots","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2011.07.004_bib0115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 10","key":"10.1016\/j.tips.2011.07.004_bib0120","doi-asserted-by":"crossref","first-page":"10E","DOI":"10.1016\/j.amjcard.2009.09.014","article-title":"Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial","volume":"104","author":"Barter","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.tips.2011.07.004_bib0125","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.108.790733","volume":"118","author":"Nicholls","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2011.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.106.138347","article-title":"Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL","volume":"27","author":"Yvan-Charvet","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tips.2011.07.004_bib0135","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2011.07.004_bib0140","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/en.2008-1512","article-title":"Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition","volume":"150","author":"Hu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2011.07.004_bib0145","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/HJH.0b013e32833b1f8e","article-title":"Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels","volume":"28","author":"Clerc","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tips.2011.07.004_bib0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/FJC.0b013e3181cf03cb","article-title":"Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition","volume":"55","author":"Connelly","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.tips.2011.07.004_bib0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/eurheartj\/ehp601","article-title":"Safety and tolerability of dalcetrapib (RO4607381\/JTT-705): results from a 48-week trial","volume":"31","author":"Stein","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tips.2011.07.004_bib0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1185\/03007995.2010.536207","article-title":"Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation","volume":"27","author":"Kastelein","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.tips.2011.07.004_bib0165","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ahj.2009.09.017","article-title":"Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome","volume":"158","author":"Schwartz","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.tips.2011.07.004_bib0170","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1009744","article-title":"Safety of anacetrapib in patients with or at high risk for coronary heart disease","volume":"363","author":"Cannon","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2011.07.004_bib0175","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/ATVBAHA.110.207142","article-title":"Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib","volume":"30","author":"Yvan-Charvet","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614711001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614711001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T16:48:08Z","timestamp":1639673288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614711001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0165614711001350"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2011.07.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}